EUVIMEDOdkrijte EUVIMED
Crossref

The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway

Wen-Yuan Zhang, Qian-Qian Wei, Tao Zhang, Chunmei Geng, Hai-Yan Wu, Chang-Shui Wang, Jing Chen iD, Lei Feng, Pei Jiang

British Journal of Pharmacology · 2026-06 · 183 (11) · 2695-2719

DOI: 10.1111/bph.70358 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-02-07. Written by Wen-Yuan Zhang and 8 co-authors. Institution: Department of Pharmacy, Zhongshan City People's Hospital, Zhongshan, China. Major MEDLINE topics: NF-E2-Related Factor 2, Basic-Leucine Zipper Transcription Factors, Doxorubicin, Aminolevulinic Acid. Cited 1 times so far (Crossref); 60 references. Funded by: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation General Program, Key R&D Program of Jining.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Background and Purpose Despite breakthroughs in immunotherapy and targeted therapies, chemotherapy remains indispensable in oncology. Experimental Approach This study seeks to pinpoint key pathways in doxorubicin (DOX)‐treated mouse hippocampus, utilising comprehensive transcriptomic and metabolomic analyses, and validating the mechanisms in vitro and in vivo. Key Results Our multi‐omics investigation revealed that sustained DOX exposure induced significant down‐regulation of 5‐aminolevulinate synthase 2 (ALAS2) and its catalytic product 5‐aminolevulinic acid (5‐ALA) in the hippocampal region. ALAS2 deficiency was specific to hippocampal neurons, which were more sensitive to oxidative damage than astrocytes or microglia. In vivo and in vitro studies demonstrated that 5‐ALA administration or ALAS2 overexpression protected the brain from DOX‐induced neurotoxicity. ALAS2 catalyses the condensation of glycine and succinyl‐CoA to form 5‐ALA, the key precursor of haem. Beyond its role in erythropoiesis, haem is a metabolite that modulates cellular redox homeostasis through interactions with the BACH1 (BTB and CNC homology 1)/NRF2 (nuclear factor erythroid 2 like 2) pathway. We found that DOX suppressed the ALAS2/5‐ALA axis, thereby enhancing BACH1 stability. This stabilised BACH1 competes with NRF2 for binding to antioxidant response elements (AREs) in target gene promoters. Conversely, reinforcing the ALAS2/5‐ALA axis elevated intracellular haem levels, promoting BACH1 degradation and enhancing NRF2 activity. Using a zebrafish model, we further highlighted the antioxidant and neuroprotective role of 5‐ALA against DOX‐induced neurotoxicity. Conclusions and Implications In conclusion, this study elucidates a novel endogenous neuroprotective mechanism wherein the ALAS2/5‐ALA axis modulates the BACH1/NRF2 pathway. 5‐ALA shows promise for repurposing to mitigate chemotherapy‐associated neurotoxicity.

Subjects

MeSH terms (MEDLINE)

NF-E2-Related Factor 2Basic-Leucine Zipper Transcription FactorsDoxorubicinAminolevulinic Acid5-Aminolevulinate SynthetaseNeuronsNeurotoxicity SyndromesAnimalsMiceZebrafishHippocampusSignal TransductionMale

Author keywords

ALAS2/5‐ALA axisBACH1/NRF2 pathwaydoxorubicinneurotoxicityoxidative stress

Substances

NF-E2-Related Factor 2Basic-Leucine Zipper Transcription FactorsDoxorubicinAminolevulinic Acid5-Aminolevulinate SynthetaseBach1 protein, mouseNfe2l2 protein, mouse

Authors and institutions

  • Department of Pharmacy, Zhongshan City People's Hospital, Zhongshan, China.
  • School of Pharmaceutical Sciences, Zunyi Medical University, Zunyi, China.
  • Translational Pharmaceutical Laboratory, Jining No.1 People's Hospital, Shandong First Medical University, Jining, China.
  • Shandong Provincial Key Medical and Health Laboratory of Neuroinjury and Repair, Jining No.1 People's Hospital, Jining, China.
  • Department of Pharmacy, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Zhongshan Psychological Society, Academic Committee, Zhongshan, China.

ORCID profiles: Jing Chen

Funding

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation General Program
  • Key R&D Program of Jining

Cite

APA

Zhang, W. Y., Wei, Q. Q., Zhang, T., Geng, C., Wu, H. Y., Wang, C. S., Chen, J., Feng, L., & Jiang, P. (2026). The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway. British Journal of Pharmacology, 183(11), 2695-2719. https://doi.org/10.1111/bph.70358

Vancouver

Zhang WY, Wei QQ, Zhang T, Geng C, Wu HY, Wang CS, et al. The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway. British Journal of Pharmacology. 2026;183(11):2695-2719. doi:10.1111/bph.70358

BibTeX
@article{Zhang2026,
  author = {Zhang, Wen-Yuan and Wei, Qian-Qian and Zhang, Tao and Geng, Chunmei and Wu, Hai-Yan and Wang, Chang-Shui and Chen, Jing and Feng, Lei and Jiang, Pei},
  title = {The neuronal ALAS2/5‐ala axis mitigates chemotherapy‐induced neurotoxicity via the BACH1/NRF2 pathway},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {11},
  pages = {2695--2719},
  doi = {10.1111/bph.70358}
}
Start for free →